Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Laizer Kornwasser currently holds 99,929 shares of Valeant Pharmaceuticals International, Inc. (VRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Laizer Kornwasser has been a net seller of VRX stock. They have purchased $1.6M and sold $12.5M worth of shares.
Laizer Kornwasser's most recent insider trade was on Aug 2, 2024, when they sold 10,879 shares at $8.14 per share.
Laizer Kornwasser serves as Executive at Valeant Pharmaceuticals International, Inc. (VRX). They have executed 96 insider transactions totaling $14.1M over their tenure at the company.
Laizer Kornwasser holds the position of Executive at Valeant Pharmaceuticals International, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Laizer Kornwasser has shown a selling trading pattern, with $1.6M in total purchases and $12.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Laizer Kornwasser was on Apr 28, 2014, when they sold $2.8M worth of VRX shares. This transaction involved 23,333 shares at $122.05 per share.
Laizer Kornwasser currently owns 99,929 shares of Valeant Pharmaceuticals International, Inc. (VRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Laizer Kornwasser's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Laizer Kornwasser has 96 Form 4 filings on record as an insider at Valeant Pharmaceuticals International, Inc..
Set alerts for Laizer Kornwasser and 40,000+ other insiders.